Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Versatis in Pediatric Neuropathic and Sickle Cell Pain
NCT01314300Phase 2Completed
- Sponsor
- Centre Léon Bérard
- Start
- Mar 2011
- Primary completion
- Jul 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of lidocaine in neuropathic pain, sickle cell disease (SCD), sponsored by Centre Léon Bérard. Started Mar 2011; status: completed.
02
Drugs
lidocaine
03
Conditions
neuropathic painsickle cell disease (SCD)
Beyond the preview
Go deeper on NCT01314300.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01314300.